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and Pharmacovigilance seeks to serve as manual for stu-
dents and reference for practitioners in the field of drug
safety. It is a lofty objective to fulfill both of these roles,
and the book seems to serve best as a reference manual
for those actively practicing in the field.
The manual is well organized and edited, and it
includes a CD with a portable document format (pdf)
version of the book. The introduction admits that ‘ge-
nomics is barely mentioned in this book’, and indeed, the
book has stayed true to this promise. Ignoring this major
topic in the field of drug safety and pharmacovigilance
further supports the assertion that the appropriate role
for this book is as a reference for the practitioner in a
drug safety department rather than a new student text.
The book starts by giving the obligate definitions of the
terms that will be covered in the subsequent chapters.
The chapters then progress logically, focusing first on
issues of drug safety from clinical trials, then post-
marketing vigilance, a discussion of the entities respon-
sible for monitoring and enforcement, and then the
populations affected by drug administration. The book
then moves into the specifics of how the practitioner
can effectively monitor and report adverse drug reac-
tions. These chapters are where the book truly shines.
Chapter 8, entitled ‘Where the Data Resides’, is an excel-
lent overview of global data collection devices and theirCorrespondence: andrew.monte@ucdenver.edu
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reproduction in any medium, provided the orstrengths and weaknesses. The book has excellent online
references covering drug safety links, such as Motherisk
and AERs, as well as regulatory websites, such as the
United States Food and Drug Administration and the
European Medicines Evaluation Agency. Unfortunately,
the websites have not been included in the text in order
to save space. This decision makes the text more read-
able but makes it more difficult to access the informa-
tion when needed for reference. The web links are listed
at the end of the book and are ‘active links’ in the pdf
version on the included CD. While the book generally
provides a brief synopsis of a topic with bulleted points
or references, occasionally, authors over-quote regula-
tory documents when the reference itself would suffice
or over-bullet, which makes the associated section diffi-
cult to read. Chapter 37, the chapter discussing the
International Conference on Harmonization, suffers
from these flaws. The topic is essential for a student
who is new to the field and to a practitioner needing an
easy reference, but the chapter has too little background
information and is over-bulleted, making it unreadable.
Contrast to this format with chapter 40, entitled
‘Organization of a Typical Drug Safety Department’, the
author gives an excellent overview of the structure of a
drug safety department with practical advice about how
to establish such a department. Each chapter concludes
with the ‘frequently asked questions’ which lends depth
to the respective chapters. These questions seem to
serve as thought-provoking tools for students since the
chapters often lack the discussion necessary for student
level learners.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cepts, and future direction of the field should continue to
use such books as the Textbook of Pharmacoepidemiology
or Stephen's Detection of New Adverse Drug Reactions.
Despite its shortcomings for a new student in the field,
Cobert's Manual of Drug Safety and Pharmacovigilance
concisely places a large amount of information essential to
the daily activities of a drug safety department in one easy-
to-navigate text. This book is an essential reference for
those working in the field of drug safety.
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